Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tubulin beta 8 class VIII pseudogene 10 (TUBB8P10) is classified as a pseudogene in the human genome and does not code for a functional protein[10][8][7][9]. It is listed in major gene nomenclature databases, such as the HUGO Gene Nomenclature Committee (HGNC), as a pseudogene and is not known to participate in biological processes or to have disease associations, drug interactions, or established mechanisms of action[10][8][7][9]. Pseudogenes like TUBB8P10 may originate from gene duplication or retrotransposition events but have accumulated mutations that prevent their expression as a functional protein. Unlike its protein-coding relative TUBB8, which is important in oocyte maturation and early embryonic development, TUBB8P10 is not a functional therapeutic target and is not considered biologically active[3][5][12][13].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tubulin beta 8 class VIII pseudogene 10 (TUBB8P10).